Author:
García-Galán A.,De la Fe C.,Gomis J.,Bataller E.,Sánchez A.,Quereda J. J.,García-Roselló E.,Gómez-Martín A.
Abstract
Abstract
Background
Mycoplasma bovis is an important pathogen for the cattle industry worldwide causing significant economic losses. Several transmission routes, including those related to reproduction, have been described. Indeed, the pathogen can colonize the female reproductive tract after artificial insemination (AI) with contaminated semen. Lactobacillus spp.-based probiotics have been used for vaginal dysbiosis treatment in women and cows although their role in controlling cervico-vaginal infections due to M. bovis is unknown. The objective of the present work is to assess the viability of M. bovis (PG45, NCTC 10131) in experimentally contaminated cervical mucus after the addition of Lactobacillus spp. at different concentrations as a competing agent and pH acidifier.
Results
The addition of probiotic at a concentration higher than 108 colony forming units (CFU/mL had a detrimental effect (P < 0.05) on mycoplasma viability in cervical mucus. This coincided with a significant LAB growth and an important decrease in pH from 8.4 to 5.6 (P < 0.05). However, after the addition of less concentrated probiotic, M. bovis survival was not affected and there was no significant LAB growth despite the drop of pH from 8.4 to 6.73 (P < 0.05).
Conclusion
The addition of concentrations higher than 108 CFU/mL of Lactobacillus spp. negatively affects M. bovis viability in bovine cervical mucus under in vitro conditions. Although the effect observed on the pathogen viability seems to be related to the pH decrease after LAB proliferation in cervical mucus, further studies are necessary to elucidate if other factors are implicated. Nevertheless, the administration of Lactobacillus spp.-based probiotics might be used in the future to control M. bovis proliferation in the cervico-vaginal tract of cows.
Funder
Ministerio de Economía y Competitividad, cofinanced by FEDER funds
Universidad CEU Cardenal Herrera
State Subprogram Training of the State Program for the Promotion of Talent and its Employability
Fundación Banco Santander
Publisher
Springer Science and Business Media LLC
Subject
General Veterinary,General Medicine
Reference37 articles.
1. Nicholas RA, Ayling RD. Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci. 2003;74:105–12.
2. Hirth RS, Nielsen SW, Plastridge WN. Bovine salpingo-oophoritis produced with semen containing a Mycoplasma. Pathol Vet. 1966;3:616–32.
3. Ruhnke HL. Mycoplasmas associated with bovine genital tract infections. In: Whitford HW, Rosenbusch RF, Lauerman LH, editors. Mycoplasmosis in animals. Ames: Iowa State University Press; 1994. p. 56–61.
4. Haapala V, Pohjanvirta T, Vähänikkila N, Halkilahti J, Simonen H, Pelkonen S, Soveri T, Simojoki H, Autio T. Semen as a source of Mycoplasma bovis mastitis in dairy herds. Vet Microbiol. 2018;216:60–6.
5. Tsiligianni T, Karagiannidis A, Brikas P, Saratsis P. Chemical properties of bovine cervical mucus during normal estrus and estrus induced by progesterone and/or PGF2α. Theriogenology. 2001;56:41–50.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献